NCT03511417

Brief Summary

The investigators will examine the effectiveness of selected over-the-counter personal sound amplifiers in addressing functional hearing problems in middle-aged listeners with mild hearing loss. Many people are unlikely to pay several thousand dollars for hearing aids but they likely would be more willing to try a possible solution that is less expensive. When faced with counseling these individuals, audiologists are at a loss regarding whether or not to suggest that they try this type of technology, since there is virtually no research available to verify that these devices actually are helpful, particularly for individuals with mild hearing loss. The hypothesis being tested is that personal sound amplifiers can improve functional hearing and decrease cognitive load in complex auditory environments.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Oct 2018

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 9, 2018

Completed
18 days until next milestone

First Posted

Study publicly available on registry

April 27, 2018

Completed
6 months until next milestone

Study Start

First participant enrolled

October 16, 2018

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 17, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 17, 2020

Completed
Last Updated

October 20, 2021

Status Verified

October 1, 2021

Enrollment Period

1.3 years

First QC Date

April 9, 2018

Last Update Submit

October 12, 2021

Conditions

Outcome Measures

Primary Outcomes (4)

  • Speech Perception

    The change in the ability to understand sentences presented in background noise

    every two weeks until asymptotic performance is noted (up to 12 weeks)

  • Cognitive Load

    The change in the ability to remember speech that has previously been presented in background noise

    every two weeks until asymptotic performance is noted (up to 12 weeks)

  • Localization Ability

    The change in the ability to indicate where a sound is coming from when presented in background noise

    every two weeks until asymptotic performance is noted (up to 12 weeks)

  • Self-Perceived Listening Effort

    Changes in how difficult it is to understand speech in background noise

    every two weeks until asymptotic performance is noted (up to 12 weeks)

Secondary Outcomes (2)

  • Self-perceived hearing device benefit

    daily during field trial (up to 12 weeks)

  • Overall perceived benefit from hearing device

    every two weeks until asymptotic performance is noted (up to 12 weeks)

Study Arms (1)

Middle-aged adults

EXPERIMENTAL

Participants will use an over-the-counter hearing device in one ear until asymptotic speech perception performance is noted (maximum 12 weeks). The same individuals will use over-the-counter hearing devices in each ear until asymptotic performance is noted (the order of these two phases will be randomized across participants). They will be asked to use these devices at least 4 hours/day.

Device: over-the-counter hearing device

Interventions

Individuals will use commercially-available over-the-counter hearing devices for specified periods of time.

Middle-aged adults

Eligibility Criteria

Age40 Years - 64 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age 40-64 years
  • Mild to moderate high frequency hearing loss
  • Learned English as a first language

You may not qualify if:

  • Previous use of hearing aids
  • Hearing loss/problems attributed to factors other than aging
  • History of: neurologic disorder, middle-ear disease
  • Score of \< 26 on the Montreal Cognitive Assessment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Massachusetts Amherst

Amherst, Massachusetts, 01003, United States

Location

MeSH Terms

Conditions

Hearing Loss, Functional

Condition Hierarchy (Ancestors)

Hearing LossHearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsBehavioral SymptomsBehavior
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor and Chair

Study Record Dates

First Submitted

April 9, 2018

First Posted

April 27, 2018

Study Start

October 16, 2018

Primary Completion

January 17, 2020

Study Completion

January 17, 2020

Last Updated

October 20, 2021

Record last verified: 2021-10

Data Sharing

IPD Sharing
Will not share

Locations